http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015514789-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0039 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J53-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 |
filingDate | 2013-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2015514789-A |
titleOfInvention | Use of 18-methyl-15β, 16β-methylene-19-nor-20-spiroxa-4-en-3-one in the treatment of hypermenorrhea and 18-methyl-15β, 16β for the treatment of uterine bleeding disorders Intrauterine system containing methylene-19-nor-20-spiroxa-4-en-3-one |
abstract | The present invention relates to a general formula (1) in the treatment of hypermenorrhea, generally in the treatment of uterine bleeding disorders: Formula (1) (Wherein R 6 and R 7 are hydrogen atoms or are present together as an α-methylene group) Of 18-methyl-15β, 16β-methylene-19-nor-20-spiroxa-4-en-3-one as well as an intrauterine system comprising a compound of formula 1 for the use. |
priorityDate | 2012-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 112.